Coloplast A/S (CLPBF)
74.24
-0.08
(-0.10%)
USD |
OTCM |
Nov 18, 16:00
Coloplast Enterprise Value : 19.92B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 19.92B |
| November 17, 2026 | 19.94B |
| November 16, 2026 | 20.18B |
| November 13, 2026 | 20.01B |
| November 12, 2026 | 19.82B |
| November 11, 2026 | 19.82B |
| November 10, 2026 | 19.54B |
| November 09, 2026 | 20.18B |
| November 06, 2026 | 19.58B |
| November 05, 2026 | 19.58B |
| November 04, 2026 | 19.58B |
| November 03, 2026 | 19.58B |
| November 02, 2026 | 18.80B |
| October 30, 2026 | 19.25B |
| October 29, 2026 | 19.25B |
| October 28, 2026 | 18.97B |
| October 27, 2026 | 18.97B |
| October 26, 2026 | 18.97B |
| October 23, 2026 | 18.97B |
| October 22, 2026 | 18.97B |
| October 21, 2026 | 18.97B |
| October 20, 2026 | 18.97B |
| October 19, 2026 | 19.01B |
| October 16, 2026 | 19.01B |
| October 15, 2026 | 19.01B |
| Date | Value |
|---|---|
| October 14, 2026 | 17.08B |
| October 13, 2026 | 17.08B |
| October 12, 2026 | 17.08B |
| October 09, 2026 | 17.08B |
| October 08, 2026 | 17.08B |
| October 07, 2026 | 17.08B |
| October 06, 2026 | 17.08B |
| October 05, 2026 | 17.35B |
| October 02, 2026 | 17.35B |
| October 01, 2026 | 17.35B |
| September 30, 2026 | 17.35B |
| September 29, 2026 | 17.67B |
| September 28, 2026 | 17.67B |
| September 25, 2026 | 17.67B |
| September 24, 2026 | 17.67B |
| September 23, 2026 | 17.67B |
| September 22, 2026 | 17.67B |
| September 21, 2026 | 17.67B |
| September 18, 2026 | 17.56B |
| September 17, 2026 | 17.56B |
| September 16, 2026 | 17.56B |
| September 15, 2026 | 18.91B |
| September 14, 2026 | 18.91B |
| September 11, 2026 | 18.91B |
| September 10, 2026 | 18.91B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ambu A/S | 3.019B |
| Abbott Laboratories | 208.41B |
| AngioDynamics, Inc. | 457.01M |
| Alphatec Holdings, Inc. | 1.621B |
| AtriCure, Inc. | 2.733B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 182.54M |
| Revenue (Quarterly) | 1.148B |
| Total Expenses (Quarterly) | 965.47M |
| EPS Diluted (Quarterly) | 0.8099 |
| Gross Profit Margin (Quarterly) | 65.50% |
| Profit Margin (Quarterly) | 15.90% |
| Earnings Yield | 2.84% |
| Operating Earnings Yield | 6.84% |
| Normalized Earnings Yield | 4.866 |